Journal Article

DKFZ-2024-01620

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.

Hansford, J. R. ; Bouche, G. ; Ramaswamy, V. ; Jabado, N. ; Fonseca, A. ; Moloney, S. ; Gottardo, N. G. ; Robinson, G. W. ; Gajjar, A. ; Tinkle, C. L. ; Fisher, P. G. ; Foreman, N. ; Ashley, D. M. ; Ziegler, D. S. ; Eisenstat, D. D. ; Massimino, M. ; Witt, O.DKFZ* ; Bartels, U.DKFZ* ; Rutkowski, S. ; Hargrave, D. ; Fouladi, M. ; Pfister, S. M.DKFZ* ; Bouffet, E.

2024
American Society of Clinical Oncology Alexandria, Va.

This record in other databases:  

Please use a persistent id in citations: doi:10.1200/JCO.24.00709

Abstract: Our international team highlights issues with efficacy reports in several studies on DMG with the new drug ONC201.

Note: 2024 Dec 10;42(35):4126-4129

---

Contributing Institute(s):

1. B062 Pädiatrische Neuroonkologie (B062)
2. DKTK HD zentral (HD01)
3. KKE Pädiatrische Onkologie (B310)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2024

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Essential Science Indicators ; IF >= 40 ; JCR ; Nationallizenz ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---